AbbVie Inc
Held by 19 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 00287Y109 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 19 of the investors we track own this stock. In the latest quarter, 11 of them bought more of it and 7 sold some or all of theirs (4 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
19
+3 vs last quarter (like-for-like)
Total value held
$12.10B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
0.5%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$2.35B
+71.1% vs last quarter
Net shares bought
+7.3M
Est. net flow +$1.83B
Quarter activity
11 bought · 7 sold
4 new · 1 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns ABBV?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns ABBV? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↓ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank | Norges Bank Investment Management | 25.55M | $6.43B | 0.6% | — | — | — | — |
| 2 | Ken Fisher | Fisher Asset Management | 9.50M | $2.39B | 0.7% | Added | +405.9K | +4.5% | +$102.14M |
| 3 | Boston Partners | Boston Partners Global Investors | 4.78M | $1.20B | 1.1% | Added | +1.4M | +39.3% | +$339.34M |
| 4 | Ken Griffin | Citadel Advisors | 3.17M | $797.64M | 0.5% | Added | +2.7M | +546.5% | +$674.27M |
| 5 | David Shaw | D.E. Shaw & Co. | 2.10M | $529.03M | 0.3% | Added | +1.4M | +212.4% | +$359.68M |
| 6 | Israel Englander | Millennium Management | 1.52M | $381.61M | 0.3% | Added | +840.7K | +124.4% | +$211.56M |
| 7 | Mawer | Mawer Investment Management | 431.25K | $108.52M | 0.7% | Added | +121.4K | +39.2% | +$30.54M |
| 8 | Steve Cohen | Point72 Asset Management | 366.84K | $92.31M | 0.1% | New | +366.8K | — | +$92.31M |
| 9 | Two Sigma | Two Sigma Investments | 198.25K | $49.89M | 0.0% | Added | +19.8K | +11.1% | +$4.99M |
| 10 | Larry Robbins | Glenview Capital | 148.91K | $37.47M | 0.7% | New | +148.9K | — | +$37.47M |
| 11 | Bridgeway | Bridgeway Capital Management | 109.54K | $27.57M | 0.5% | Reduced | -2.5K | -2.3% | -$637.40K |
| 12 | Torray | Torray Investment Partners | 82.60K | $20.79M | 2.8% | Reduced | -11.0K | -11.7% | -$2.76M |
| 13 | Fred Alger | Fred Alger Management | 67.74K | $17.05M | 0.1% | Reduced | -41.1K | -37.7% | -$10.34M |
| 14 | Mario Gabelli | GAMCO Investors | 13.60K | $3.42M | 0.0% | Reduced | -1.5K | -10.1% | -$382.74K |
| 15 | Ray Dalio | Bridgewater Associates | 11.78K | $2.96M | 0.0% | Reduced | -18.6K | -61.2% | -$4.68M |
| 16 | Dodge & Cox | Dodge & Cox | 10.39K | $2.62M | 0.0% | Held | 0 | 0.0% | $0 |
| 17 | John Ciampaglia & Eric Sprott | Sprott Inc | 7.75K | $1.95M | 0.1% | New | +7.7K | — | +$1.95M |
| 18 | Bill Nygren | Harris Associates (Oakmark Funds) | 2.42K | $608.97K | 0.0% | Reduced | -262 | -9.8% | -$65.93K |
| 19 | Jeremy Grantham | GMO | 885 | $222.70K | 0.0% | New | +885 | — | +$222.70K |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Ron Baron | Baron Capital (BAMCO) | -8.0K | $1.74M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ro Khanna Politician | Sep 4, 2026 | ABBV | ABBVIE INC. CMN scanned | Sale (partial) | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Oct 7, 2026 | 33 days | PTR ↗ |
| Pete Sessions Politician | Sep 14, 2026 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | ET IRA | Sep 18, 2026 | 4 days | PTR ↗ |
| Ro Khanna Politician | Jun 2, 2026 | ABBV | ABBVIE INC. CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jul 6, 2026 | 34 days | PTR ↗ |
| Ro Khanna Politician | May 1, 2026 | ABBV | ABBVIE INC. CMN scanned | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Child | — | Jun 9, 2026 | 39 days | PTR ↗ |
| Ro Khanna Politician | May 15, 2026 | ABBV | ABBVIE INC. CMN scanned | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Jun 9, 2026 | 25 days | PTR ↗ |
| Josh Gottheimer Politician | May 5, 2026 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Morgan Stanley - Select UMA Account # 1 | Jun 3, 2026 | 29 days | PTR ↗ |
| Ro Khanna Politician | Apr 13, 2026 | ABBV | ABBVIE INC. CMN scanned | Sale (partial) | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | May 11, 2026 | 28 days | PTR ↗ |
| Ro Khanna Politician | Jan 23, 2026 | ABBV | ABBVIE INC. CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Feb 6, 2026 | 14 days | PTR ↗ |
| Ro Khanna Politician | Jan 29, 2026 | ABBV | ABBVIE INC. CMN scanned | Exchange | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Feb 6, 2026 | 8 days | PTR ↗ |
| Julie Johnson Politician | Dec 18, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Chase Brokerage Account (3935) | Jan 15, 2026 | 28 days | PTR ↗ |
| Julia Letlow Politician | Dec 8, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 36 days | PTR ↗ |
| Julia Letlow Politician | Oct 23, 2024 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 447 days Late | PTR ↗ |
| Julia Letlow Politician | Jan 24, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 354 days Late | PTR ↗ |
| Julia Letlow Politician | Apr 28, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 260 days Late | PTR ↗ |
| Julie Johnson Politician | Nov 13, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Chase Brokerage Account (3935) | Dec 11, 2025 | 28 days | PTR ↗ |
| Lisa McClain Politician | Oct 30, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 30, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 31, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 21 days | PTR ↗ |
| Julie Johnson Politician | Aug 14, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Chase Brokerage Account (3935) | Sep 11, 2025 | 28 days | PTR ↗ |
| Ro Khanna Politician | Aug 4, 2025 | ABBV | ABBVIE INC, CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Sep 9, 2025 | 36 days | PTR ↗ |
| Ritchie Torres Politician | Sep 26, 2024 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | — | Aug 20, 2025 | 328 days Late | PTR ↗ |
| Ritchie Torres Politician | Jul 11, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | — | Aug 20, 2025 | 40 days | PTR ↗ |
| Lisa McClain Politician | Jun 17, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 57 days Late | PTR ↗ |
| Lisa McClain Politician | Jul 22, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Jul 22, 2025 | ABBV | AbbVie Inc. Common Stock (ABBV) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 22 days | PTR ↗ |